Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Angiodynamics Inc (ANGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 822,213
  • Shares Outstanding, K 37,137
  • Annual Sales, $ 344,290 K
  • Annual Income, $ 16,340 K
  • 60-Month Beta 0.75
  • Price/Sales 2.39
  • Price/Cash Flow 16.05
  • Price/Book 1.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/28/19
See More
  • Average Estimate 0.22
  • Number of Estimates 1
  • High Estimate 0.22
  • Low Estimate 0.22
  • Prior Year 0.25
  • Growth Rate Est. (year over year) -12.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.07 +6.31%
on 03/07/19
23.21 -3.49%
on 02/25/19
-0.03 (-0.13%)
since 02/21/19
3-Month
18.50 +21.08%
on 12/31/18
23.92 -6.35%
on 02/20/19
+3.17 (+16.48%)
since 12/21/18
52-Week
15.26 +46.79%
on 03/29/18
24.49 -8.53%
on 09/26/18
+5.70 (+34.13%)
since 03/21/18

Most Recent Stories

More News
AngioDynamics to Report Fiscal 2019 Third Quarter Financial Results on April 2, 2019

AngioDynamics, Inc.(NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that...

ANGO : 22.32 (+0.81%)
Avanos (AVNS) Q4 Earnings Beat, Revenues Miss, Shares Down

Avanos (AVNS) registers solid growth in the Chronic Care and Pain Management segments in Q4.

AVNS : 42.50 (+1.26%)
VAR : 137.81 (+1.47%)
ANGO : 22.32 (+0.81%)
CNMD : 82.12 (+2.48%)
AngioDynamics Wins Patent Infringement Dispute With Bard

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that...

ANGO : 22.32 (+0.81%)
AMN Healthcare (AMN) Q4 Earnings Top, Revenues Lag Estimates

AMN Healthcare's (AMN) Q4 results get a boost from Nurse and Allied Solutions and Other Workforce Solutions segments.

AMN : 49.27 (+2.48%)
VAR : 137.81 (+1.47%)
ANGO : 22.32 (+0.81%)
CNMD : 82.12 (+2.48%)
Cooper Companies' (COO) Q1 Earnings Beat, Revenues Rise Y/Y

Strong performance by Cooper Companies' (COO) CSI and CVI segments drove the top line in first-quarter fiscal 2019.

COO : 297.13 (+2.03%)
VAR : 137.81 (+1.47%)
ANGO : 22.32 (+0.81%)
CNMD : 82.12 (+2.48%)
GNC Holdings' (GNC) Q4 Earnings Miss Estimates, Margins Fall

GNC Holdings' (GNC) international segment registers revenue growth in the fourth quarter.

ABMD : 337.65 (-0.59%)
ANGO : 22.32 (+0.81%)
CNMD : 82.12 (+2.48%)
GNC : 2.73 (+2.63%)
Here's Why You Should Invest in AngioDynamics Stock Now

Expanding customer base of the NanoKnife platform is likely to fortify AngioDynamics' (ANGO) foothold in the Medical Instruments space.

WMGI : 32.24 (+0.37%)
ABMD : 337.65 (-0.59%)
IDXX : 225.88 (+3.01%)
ANGO : 22.32 (+0.81%)
HMS Holdings' (HMSY) Q4 Earnings Beat, Revenues Rise Y/Y

Strong performance in Analytical Services drove HMS Holdings' (HMSY) performance in Q4.

VAR : 137.81 (+1.47%)
HMSY : 32.84 (+0.52%)
ANGO : 22.32 (+0.81%)
CNMD : 82.12 (+2.48%)
PRA Health's (PRAH) Q4 Earnings Top, Revenues Lag Estimates

PRA Health (PRAH) gains from solid segmental contributions in Q4.

VAR : 137.81 (+1.47%)
ANGO : 22.32 (+0.81%)
PRAH : 107.92 (+0.19%)
CNMD : 82.12 (+2.48%)
Inogen (INGN) Q4 Earnings Beat Estimates, Rental Revenues Up

Inogen (INGN) gains from solid direct-to-consumer revenues in Q4; strong business-to-business revenues in the United States.

VAR : 137.81 (+1.47%)
ANGO : 22.32 (+0.81%)
CNMD : 82.12 (+2.48%)
INGN : 94.71 (+1.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade ANGO with:

Business Summary

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad...

See More

Key Turning Points

2nd Resistance Point 22.67
1st Resistance Point 22.41
Last Price 22.32
1st Support Level 21.93
2nd Support Level 21.71

See More

52-Week High 24.49
Last Price 22.32
Fibonacci 61.8% 20.96
Fibonacci 50% 19.88
Fibonacci 38.2% 18.79
52-Week Low 15.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar